tiprankstipranks
Exscientia Plc Gains Strong Shareholder Support
PremiumCompany AnnouncementsExscientia Plc Gains Strong Shareholder Support
14d ago
EXAI Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
EXAI Upcoming Earnings Report: What to Expect?
15d ago
Exscientia Plc Faces Financial Challenges Amid Rising Costs
Premium
Company Announcements
Exscientia Plc Faces Financial Challenges Amid Rising Costs
18d ago
Exscientia’s Strategic Merger and Pipeline Progress
PremiumCompany AnnouncementsExscientia’s Strategic Merger and Pipeline Progress
3M ago
Exscientia reports Q2 EPS (36c) vs. (37c) last year
Premium
The Fly
Exscientia reports Q2 EPS (36c) vs. (37c) last year
3M ago
Small Cap Stocks: Recursion Pharmaceuticals (RXRX) Applying AI and Strategic Partnerships
Premium
Market News
Small Cap Stocks: Recursion Pharmaceuticals (RXRX) Applying AI and Strategic Partnerships
3M ago
Recursion Pharmaceuticals to combine with Exscientia in all-stock deal
PremiumThe FlyRecursion Pharmaceuticals to combine with Exscientia in all-stock deal
4M ago
Exscientia price target lowered to $9 from $10 at Barclays
Premium
The Fly
Exscientia price target lowered to $9 from $10 at Barclays
4M ago
Exscientia Secures Full Rights to Novel Cancer Drug
Premium
Company Announcements
Exscientia Secures Full Rights to Novel Cancer Drug
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100